Stock Buybacks!™ and the Monetization of Stock-Based Compensation

Ben Hunt

November 9, 2022·30 comments

The circular process of issuing new shares to employees and then buying those shares back with company money - MY money as a shareholder - is called 'sterilization'.

Sterilization has been around forever, and to a limited degree it's fine. Yes, management teams should get some reasonable level of stock-based compensation. Yes, it may make sense to use some of my cash to sterilize those shares and keep the share count from expanding. But don't tell me that the sterilization of newly issued shares is anything other than a direct compensation expense that I am paying for with MY money. Don't tell me that the sterilization of newly issued shares is somehow a "return" of cash to ME, because it's just not. The sterilization of newly issued shares is a direct transfer of my money to YOU, the recipient of those newly issued shares. Nothing more, nothing less.

I believe that there has been a sea change in markets over the past ten years in the size and scope of these sterilizing stock buybacks.

I believe that there has been a truly astronomical transfer of wealth - well more than a trillion dollars - over the past ten years from shareholders of publicly traded companies to managers of publicly traded companies. Not founders, not entrepreneurs, not risk-takers ... managers.

I believe that this sea change has been driven by the intentional trumpeting of three narratives by management teams, boards of directors and their rah-rah Wall Street/CNBC accomplices:

 

  • "Our Interests Are Aligned" to justify larger and larger amounts of stock-based comp,
  • "Non-GAAP is the Best Way to Understand This Company's Fundamentals" to justify downplaying stock-based comp and share dilution as a crucial issue for investors, and
  • "We're Returning Cash to Shareholders" to justify the sterilization of that stock-based comp with stock buybacks.

 

Here's how it works:

 

Subscribe Today to Read More

Unlock instant access to this and hundreds of other evergreen essays that explore the world of narrative through hard science and human wisdom.

  • Make more informed decisions as an investor and citizen.
  • See through the nudges of Big Politics and Big Media.
  • Become a better consumer of news.
  • Maintain your autonomy of mind in a swarm of narratives.
  • Join a community of more than 100,000 truth-seekers.

Looking for Deeper Insights?

Unlock exclusive market intelligence, trade ideas, and member-only events tailored for investment professionals and active investors with Perscient Pro.

VISIT PRO
meta
google
googl
aapl
apple
facebook
sbc
stock-based comp
Most Popular

DISCLOSURES

This commentary is being provided to you as general information only and should not be taken as investment advice. The opinions expressed in these materials represent the personal views of the author(s). It is not investment research or a research recommendation, as it does not constitute substantive research or analysis. Any action that you take as a result of information contained in this document is ultimately your responsibility. Epsilon Theory will not accept liability for any loss or damage, including without limitation to any loss of profit, which may arise directly or indirectly from use of or reliance on such information. Consult your investment advisor before making any investment decisions. It must be noted, that no one can accurately predict the future of the market with certainty or guarantee future investment performance. Past performance is not a guarantee of future results.

Statements in this communication are forward-looking statements. The forward-looking statements and other views expressed herein are as of the date of this publication. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements, and there is no guarantee that any predictions will come to pass. The views expressed herein are subject to change at any time, due to numerous market and other factors. Epsilon Theory disclaims any obligation to update publicly or revise any forward-looking statements or views expressed herein. This information is neither an offer to sell nor a solicitation of any offer to buy any securities. This commentary has been prepared without regard to the individual financial circumstances and objectives of persons who receive it. Epsilon Theory recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial advisor. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives.